Desvenlafaxine for Treatment of Hot Flashes in Women With Breast Cancer Taking Tamoxifen

NCT02819921 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

59

Enrollment

OTHER

Sponsor class

Stopped Difficulty in Recruiting Research Participants

Conditions

Hot Flashes
Breast Neoplasms

Interventions

DRUG: Desvenlafaxine succinate 100mg
DRUG: Desvenlafaxine succinate 50mg
DRUG: Placebo

Sponsor

Seoul National University Hospital

Collaborators

[object Object]
[object Object]
[object Object]